WHO reported outbreak of western equine encephalitis in Argentina
On Dec. 28, 2023, the International Health Regulations National Focal Point (IHR NFP) of Argentina notified the World…
-
-
SARS-CoV-2 rebound with and without use of COVID-19 oral antivirals
On Dec. 22, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced study results that showed…
-
CDC projected JN.1 variant of SARS-CoV-2 to account for 39-50% of circulating variants in the U.S.
On Dec. 22, 2023, the U.S. Centers for Disease Control and Prevention (CDC) projected the JN.1 variant of…
-
CCSL and Arcturus Therapeutics’ ARCT-154 Demonstrated Non-Inferiority to Original Strain and Superior Immunogenicity to Omicron BA.4/5 Variant Compared to First-Generation mRNA Vaccine Booster
On Dec. 21, 2023, CSL and and Arcturus Therapeutics announced the results of a Phase 3 study showing…
-
R21/Matrix-M malaria vaccine granted prequalification by World Health Organization
On Dec. 21, 2023, the World Health Organization (WHO) announced that it had prequalified the R21/Matrix-M malaria vaccine…
-
First cases of highly pathogenic avian Influenza confirmed in Benton and Clatsop counties
On Dec. 20, 2023, the United States Department of Agriculture’s (USDA) National Veterinary Services Laboratory (NVSL) announced it…
-
Molecular jackhammers’ ‘good vibrations’ eradicate cancer cells
On Dec. 19, 2023, a research team led by Rice University reported they found that the atoms of…
-
COVID-19 vaccinations shifted to regular immunization as COVAX draws to a close
On Dec. 19, 2023, COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020,…
-
FDA approved first test to help identify elevated risk of developing opioid use disorder
On Dec. 19, 2023, the U.S. Food and Drug Administration approved the first test that uses DNA in…
-
Novo Nordisk Foundation announced USD $260 million vaccines initiative to fight deadly airborne infections
On Dec. 18, 2023, the Novo Nordisk Foundation announced it was committing up to DKK 1.8 billion (USD…
-
Flu vaccination during pregnancy decreased flu hospitalizations and emergency visits in infants younger than 6 months
On Dec. 18, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced a study that showed…
-
BioNTech aimed to start mRNA vaccine output in Rwanda in 2025
On Dec. 18, 2023, COVID-19 vaccine maker BioNTech (22UAy.DE) announced that it aims to start production at its…
-
Novavax’s updated COVID-19 vaccine received Emergency Use Authorization in Taiwan
On Dec. 18, 2023, Novavax announced that the Taiwan Food and Drug Administration had granted emergency use authorization…
-
W. Kimryn Rathmell, M.D., Ph.D., began work as 17th director of the National Cancer Institute
On Dec. 18, 2023, W. Kimryn Rathmell, M.D., Ph.D., began work as the 17th director of the National…
-
WHO officially recognized noma as a neglected tropical disease
On Dec. 15, 2023, In a pivotal move towards addressing one of the worldﾒs most underrecognized health challenges,…
-
Artificial Intelligence | Biotechnology | Diagnostics | Disease | Genomics | Nanotechnology | Neurology | Non-Profit Research | Pharmaceutical | Therapeutics
PNNL created Center for Artificial Intelligence
On Dec. 14, 2023, the Department of Energy’s (DOE) Pacific Northwest National Laboratory (PNNL) announced that it had…
-
CEPI and PATH strengthen partnership to accelerate development of vaccines against diseases with epidemic potential
On Dec. 14, 2023, The Coalition for Epidemic Preparedness Innovations (CEPI) and PATH today announced a renewed collaboration…
-
Pfizer completed acquisition of Seagen for $43 billion
On Dec. 14, 2023, Pfizer announced it had completed the acquisition of Seagen, a global biotechnology company based…
-
Biotechnology | Diagnostics | Disease | Genomics | Neurology | Therapeutics
Alberta researchers revealed full structure of ‘ancient genetic parasite’ implicated in human diseases
On Dec. 14, 2023, the University of Alberta announced that a study published in Nature sheds light on…
-
ZURZUVAE (zuranolone) CIV, a landmark treatment for women with postpartum Depression, available in the U.S.
On Dec. 14, 2023, Biogen and Sage Therapeutics announced ZURZUVAE (zuranolone) 50 mg (two 25 mg capsules per…
-
Biotechnology | Diagnostics | Disease | NIH | Therapeutics
Scientists unveiled complete cell map of a whole mammalian brain
On Dec. 13, 2023, for the first time ever, an international team of researchers announced they had created…
-
Allen Institute scientists and partners unveiled first complete cellular map of adult mouse brain
On Dec. 13, 2023, the Allen Institute and collaborators announced that after six years and 32 million cells,…
-
NIAID scientists found Infectious SARS-CoV-2 in patient blood
On Dec. 13, 2023, National Institute of Allergy and Infectious Diseases (NIAID) scientists announced findings published in the…
-
Using next-gen CRISPR tool, Gladstone scientists created unprecedented molecular map of human immune response
On Dec. 13, 2023, in a study of historic scale, scientists at Gladstone Institutes announced that they had…
-
CDC announced Rocky Mountain spotted fever in people traveling to the U.S. from Tecate, Mexico
On Dec. 11, 2023, the U.S. Centers for Disease Control and Prevention (CDC) issued a Health Alert Network…
-
CRISPR | FDA | Genomics | Stem Cell | Therapeutics
FDA approved first gene therapies to treat patients with sickle cell disease
On Dec. 8, 2023, the U.S. Food and Drug Administration (FDA) approved two milestone treatments, Casgevy and Lyfgenia,…
-
bluebird bio announced commercial launch of LYFGENIA’ gene therapy for patients ages 12 and older with sickle cell disease
On Dec. 8, 2023, bluebird bio announced the U.S. commercial launch of its LYFGENIA’ (lovotibeglogene autotemcel, also known…
-
Biotechnology | CRISPR | FDA | Genomics | Therapeutics
Vertex and CRISPR Therapeutics announced U.S. FDA approval of CASGEVY for treatment of sickle Cell disease
On Dec. 8, 2023, Vertex Pharmaceuticals and CRISPR Therapeutics announced that the U.S. Food and Drug Administration (FDA)…
-
The University of Virginia broke ground on Paul and Diane Manning Institute of Biotechnology
On Dec. 8, 2023, the University of Virginia broke ground Friday on the Paul and Diane Manning Institute…
-
BioNTech and Australiaﾒs State of Victoria signed agreement on strategic partnership to strengthen mRNA rcosystem
On Dec. 7, 2023, BioNTech announced that it had signed a multi-year strategic partnership with the State of…
